277 related articles for article (PubMed ID: 25534917)
21. Association of Anticoagulant Therapy With Risk of Fracture Among Patients With Atrial Fibrillation.
Lutsey PL; Norby FL; Ensrud KE; MacLehose RF; Diem SJ; Chen LY; Alonso A
JAMA Intern Med; 2020 Feb; 180(2):245-253. PubMed ID: 31764956
[TBL] [Abstract][Full Text] [Related]
22. Statin use after colorectal cancer diagnosis and survival: a population-based cohort study.
Cardwell CR; Hicks BM; Hughes C; Murray LJ
J Clin Oncol; 2014 Oct; 32(28):3177-83. PubMed ID: 25092779
[TBL] [Abstract][Full Text] [Related]
23. Evidence of increasing mortality with longer diagnostic intervals for five common cancers: a cohort study in primary care.
Tørring ML; Frydenberg M; Hansen RP; Olesen F; Vedsted P
Eur J Cancer; 2013 Jun; 49(9):2187-98. PubMed ID: 23453935
[TBL] [Abstract][Full Text] [Related]
24. Metformin and cancer-specific survival among breast, colorectal, or endometrial cancer patients: A nationwide data linkage study.
Feng JL; Qin X
Diabetes Res Clin Pract; 2021 May; 175():108755. PubMed ID: 33836207
[TBL] [Abstract][Full Text] [Related]
25. Validating billing/encounter codes as indicators of lung, colorectal, breast, and prostate cancer recurrence using 2 large contemporary cohorts.
Hassett MJ; Ritzwoller DP; Taback N; Carroll N; Cronin AM; Ting GV; Schrag D; Warren JL; Hornbrook MC; Weeks JC
Med Care; 2014 Oct; 52(10):e65-73. PubMed ID: 23222531
[TBL] [Abstract][Full Text] [Related]
26. Use of Antihypertensive Medications and Survival Rates for Breast, Colorectal, Lung, or Stomach Cancer.
Cui Y; Wen W; Zheng T; Li H; Gao YT; Cai H; You M; Gao J; Yang G; Zheng W; Xiang YB; Shu XO
Am J Epidemiol; 2019 Aug; 188(8):1512-1528. PubMed ID: 31062847
[TBL] [Abstract][Full Text] [Related]
27. Is the risk of cancer in Australia overstated? The importance of competing mortality for estimating lifetime risk.
Bach AC; Lo KS; Pathirana T; Glasziou PP; Barratt AL; Jones MA; Bell KJ
Med J Aust; 2020 Jan; 212(1):17-22. PubMed ID: 31691294
[TBL] [Abstract][Full Text] [Related]
28. The impact of expanding health insurance coverage for anti-cancer drugs on cancer survival in Korea.
Cho DY; Park J; Kim DS
Cancer Med; 2021 Jul; 10(13):4555-4563. PubMed ID: 34145980
[TBL] [Abstract][Full Text] [Related]
29. Pre-diagnostic derivatives of reactive oxygen metabolites and the occurrence of lung, colorectal, breast and prostate cancer: An individual participant data meta-analysis of two large population-based studies.
Gào X; Wilsgaard T; Jansen EH; Holleczek B; Zhang Y; Xuan Y; Anusruti A; Brenner H; Schöttker B
Int J Cancer; 2019 Jul; 145(1):49-57. PubMed ID: 30561010
[TBL] [Abstract][Full Text] [Related]
30. Sodium channel-inhibiting drugs and cancer survival: protocol for a cohort study using the CPRD primary care database.
Fairhurst C; Martin F; Watt I; Doran T; Bland M; Brackenbury WJ
BMJ Open; 2016 Sep; 6(9):e011661. PubMed ID: 27601493
[TBL] [Abstract][Full Text] [Related]
31. Prediagnostic aspirin use and mortality in women with stage I to III breast cancer: A cohort study in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Bradley MC; Black A; Freedman AN; Barron TI
Cancer; 2016 Jul; 122(13):2067-75. PubMed ID: 27149646
[TBL] [Abstract][Full Text] [Related]
32. Lower TSH and higher free thyroxine predict incidence of prostate but not breast, colorectal or lung cancer.
Chan YX; Knuiman MW; Divitini ML; Brown SJ; Walsh J; Yeap BB
Eur J Endocrinol; 2017 Oct; 177(4):297-308. PubMed ID: 28684452
[TBL] [Abstract][Full Text] [Related]
33. 5α-Reductase Inhibitors and the Risk of Cancer-Related Mortality in Men With Prostate Cancer.
Azoulay L; Eberg M; Benayoun S; Pollak M
JAMA Oncol; 2015 Jun; 1(3):314-20. PubMed ID: 26181177
[TBL] [Abstract][Full Text] [Related]
34. Association of Warfarin Use With Lower Overall Cancer Incidence Among Patients Older Than 50 Years.
Haaland GS; Falk RS; Straume O; Lorens JB
JAMA Intern Med; 2017 Dec; 177(12):1774-1780. PubMed ID: 29114736
[TBL] [Abstract][Full Text] [Related]
35. Assessment of Outcomes of Treatment With Oral Anticoagulants in Patients With Atrial Fibrillation and Multiple Chronic Conditions: A Comparative Effectiveness Analysis.
Mentias A; Shantha G; Chaudhury P; Vaughan Sarrazin MS
JAMA Netw Open; 2018 Sep; 1(5):e182870. PubMed ID: 30646182
[TBL] [Abstract][Full Text] [Related]
36. Five-year relative survival from prostate, breast, colorectal and lung cancer.
Ellison LF; Gibbons L;
Health Rep; 2001 Dec; 13(1):23-34. PubMed ID: 15069806
[TBL] [Abstract][Full Text] [Related]
37. Survival of patients newly diagnosed with colorectal cancer and with a history of previous cancer.
Pruitt SL; Gerber DE; Zhu H; Heitjan DF; Maddineni B; Xiong D; Singal AG; Tavakkoli A; Halm EA; Murphy CC
Cancer Med; 2021 Jul; 10(14):4752-4767. PubMed ID: 34190429
[TBL] [Abstract][Full Text] [Related]
38. Survival outcomes of secondary cancers in patients with Waldenström macroglobulinemia: An analysis of the SEER database.
Castillo JJ; Olszewski AJ; Kanan S; Meid K; Hunter ZR; Treon SP
Am J Hematol; 2015 Aug; 90(8):696-701. PubMed ID: 25963924
[TBL] [Abstract][Full Text] [Related]
39. Comparative Effectiveness and Safety of Direct-acting Oral Anticoagulants and Warfarin in Patients with Venous Thromboembolism and Active Cancer: An Observational Analysis.
Dawwas GK; Dietrich E; Smith SM; Davis K; Park H
Clin Ther; 2020 Sep; 42(9):e161-e176. PubMed ID: 32768247
[TBL] [Abstract][Full Text] [Related]
40. A cohort study investigating aspirin use and survival in men with prostate cancer.
Flahavan EM; Bennett K; Sharp L; Barron TI
Ann Oncol; 2014 Jan; 25(1):154-9. PubMed ID: 24356627
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]